Skip to content

Study on the treatment of allergic asthma in the elderly population in Hubei province

Study on the treatment of allergic asthma in the elderly population in Hubei province

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000563
Enrollment
Unknown
Registered
2024-10-15
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic asthma

Interventions

Sponsors

Hubei Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 99 Years

Inclusion criteria

Inclusion criteria: (1) Meet the western medical diagnostic criteria for mild to moderate allergic asthma; (2) Aged 60 years and above; (3) Voluntary participation and signing an informed consent form; (4) Those with low literacy or reading difficulties but who could understand the entries correctly with the investigator's explanation and who had obtained the informed consent of their guardians.

Exclusion criteria

Exclusion criteria: (1) Patients with comorbid chronic obstructive pulmonary disease (COPD) bronchiectasis and allergic bronchopulmonary aspergillosis (ABPA); (2) Hypersensitivity to the components of traditional Chinese medicine or budesonide/formoterol; (3) Patients who have received systemic allergen-specific immunotherapy within 1 year prior to enrolment; (4) Those with co-morbidities of malignant tumours haematological disorders psychiatric disorders or severe hepatic or renal insufficiency; (5) Those who are unable to complete auxiliary examinations such as pulmonary function tests FeNO and blood tests; (6) Participating in other drug clinical trials at the same time.

Design outcomes

Primary

MeasureTime frame
Asthma Control Test;

Secondary

MeasureTime frame
Constitution in Chinese medicine questionnaire;Asthma Control Test;IgE and sIgE;ACQ-5/ACQ-7;The fraction of exhaled nitric oxide;Asthma Quality of Life Questionnaire;lung function testing;the total dose of budesonide-formoterol and Total Asthma Symptom Score;

Countries

China

Contacts

Public ContactKeJia

Hubei Provincial Hospital of Traditional Chinese Medicine

24929135@qq.com027-88929122

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026